Last reviewed · How we verify
midazolam-based sedation
At a glance
| Generic name | midazolam-based sedation |
|---|---|
| Sponsor | Meir Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids (NA)
- Basic and Clinical Study of Cardiac Ganglion Catheter Ablation for the Treatment of Significant Bradycardia (NA)
- Comparison of Anesthetic Techniques for Early Recovery After Ankle Arthroscopy (NA)
- Prospective IR-led Sedation Feasibility (PHASE1, PHASE2)
- Comparison of the Effects of Target-Controlled Infusion Method and Manual Propofol Administration on Respiratory Function, Recovery, and Electroencephalogram in Endoscopic Submucosal Dissection Cases (NA)
- Endobronchial Valve in Tubercular and NTM Pulmonary Cavities. (NA)
- Nurse-Led BIS-Guided Sedation Protocol in Pediatric Intensive Care (NA)
- Comparison of High Flow vs Standard Nasal Cannula in Children With Burns Under Sedoanalgesia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- midazolam-based sedation CI brief — competitive landscape report
- midazolam-based sedation updates RSS · CI watch RSS
- Meir Medical Center portfolio CI